Device
Cervical transcutaneous vagus nerve stimulation (active comparator)
Cervical transcutaneous vagus nerve stimulation (active comparator) is a medical device with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
50%(1 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_1
2
67%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 12 (66.7%)
N/A1 (33.3%)
Trials by Status
completed267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingnot_applicable
Non-invasive Vagal Nerve Stimulation as Novel Treatment to Improve Functional Outcomes in Veterans With Alcohol Use Disorder
NCT06399653
completedphase_1
Non-invasive Vagal Nerve Stimulation in Alcohol Use Disorder
NCT05226130
completedphase_1
Vagal Nerve Stimulation to Probe Inflammation and Brain in Post-traumatic Stress
NCT03858985
Clinical Trials (3)
Showing 3 of 3 trials
NCT06399653Not Applicable
Non-invasive Vagal Nerve Stimulation as Novel Treatment to Improve Functional Outcomes in Veterans With Alcohol Use Disorder
NCT05226130Phase 1
Non-invasive Vagal Nerve Stimulation in Alcohol Use Disorder
NCT03858985Phase 1
Vagal Nerve Stimulation to Probe Inflammation and Brain in Post-traumatic Stress
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3